FindTrial
Sign In

OPEN-LABEL, CONTROLLED, RANDOMISED, MULTICENTRE, PARALLEL GROUP CLINICAL TRIAL OF EFFICACY AND TOLERABILITY OF FITOSTIMOLINE ANTIBIOTICO SOAKED GAUZES AND CITRIZAN GEL ANTIBIOTIC IN THE TOPICAL TREATMENT OF CUTANEOUS SORES, ULCERS AND BURNS, COMPLICATED WITH BACTERIAL CONTAMINATION the so-called infected lesions

OPEN-LABEL, CONTROLLED, RANDOMISED, MULTICENTRE, PARALLEL GROUP CLINICAL TRIAL OF EFFICACY AND TOLERABILITY OF FITOSTIMOLINE ANTIBIOTICO SOAKED GAUZES AND CITRIZAN GEL ANTIBIOTIC IN THE TOPICAL TREATMENT OF CUTANEOUS SORES, ULCERS AND BURNS, COMPLICATED WITH BACTERIAL CONTAMINATION the so-called infected lesions

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2004-000422-73-IT
Enrollment
160
Registered
2006-12-06
Start date
2004-09-28
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

TREATMENT OF CUTANEOUS SORES, ULCERS AND BURNS, COMPLICATED WITH BACTERIAL CONTAMINATION Level: HLGT Classification code 10040792

Interventions

Product Name: Fitostimoline antibiotic Pharmaceutical Form: Concentration unit: g gram(s) Concentration type: equal Concentration number: 4- Trade Name: CITRIZAN ANTIBIOTICO*GEL 50G Pharmaceutical

Sponsors

FARMACEUTICI DAMOR
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):—

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026